Taiwan
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 253.20 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Taiwan |
|
2 |
USD 122.39 M
|
Dec. 31, 2023 | USD 1.58 | NA |
|
Taiwan |
|
3 |
USD 119.23 M
|
Dec. 31, 2023 | USD 0.97 | NA |
|
Taiwan |
|
4 |
USD 118.18 M
|
Dec. 31, 2023 | USD 3.03 | NA |
|
Taiwan |
|
5 |
USD 90.63 M
|
Dec. 31, 2023 | USD 1.81 | NA |
|
Taiwan |
|
6 |
USD 33.81 M
|
Dec. 31, 2023 | USD 0.34 | NA |
|
Taiwan |
|
7 |
USD 21.14 M
|
Dec. 31, 2023 | USD 2.60 | NA |
|
Taiwan |
The Clinical Trials company in Taiwan with the highest Cash and Short-Term Investments is Oneness Biotech Co., Ltd. (Taipei Exchange: 4743.TWO) at USD 253.20 M.
The Clinical Trials company in Taiwan with the lowest Cash and Short-Term Investments is TaiMed Biologics Inc. (Taipei Exchange: 4147.TWO) at USD 21.14 M.
The top 10 Clinical Trials companies in Taiwan by Cash and Short-Term Investments are Oneness Biotech Co., Ltd., Medigen Vaccine Biologics Corporation, Microbio Co., Ltd., PharmaEngine, Inc., OBI Pharma, Inc., TaiGen Biopharmaceuticals Holdings Limited and TaiMed Biologics Inc..
The bottom 10 Clinical Trials companies in Taiwan by Cash and Short-Term Investments are TaiMed Biologics Inc., TaiGen Biopharmaceuticals Holdings Limited, OBI Pharma, Inc., PharmaEngine, Inc., Microbio Co., Ltd., Medigen Vaccine Biologics Corporation and Oneness Biotech Co., Ltd..